Korro Bio, Inc. (KRRO) Total liabilities 2019–2025
Korro Bio, Inc. (KRRO) total liabilities at each fiscal year-end, per SEC filings.
$62.1MFY2025 · since FY2019: $55.9M → $62.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $62.1M | -5.7% |
| FY2024 | $65.8M | +27.2% |
| FY2023 | $51.8M | +480.8% |
| FY2022 | $8.9M | -83.7% |
| FY2021 | $54.5M | -24.5% |
| FY2020 | $72.2M | +29.3% |
| FY2019 | $55.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRRO financial trends
KRRO RevenueKRRO Net incomeKRRO Net marginKRRO Gross profitKRRO Gross marginKRRO Operating incomeKRRO Operating marginKRRO Operating cash flowKRRO Free cash flowKRRO Capital expendituresKRRO Return on equityKRRO Stock buybacksKRRO Dividends paidKRRO Total assetsKRRO Shareholders’ equityKRRO overview →